Abciximab
Severe
Database
Drug interaction classified as: synergy
Source: DDInter
Drug reference
trastuzumab emtansine
Drug monograph
CDSCO approved
EXCRETION
—
not curated
INTERACTIONS
12 major
SEVERE in our sources
PREGNANCY
—
not curated
Top interactionssee all 12 →
- AbciximabSevereDatabaseDDInter
- AcalabrutinibSevereDatabaseDDInter
- AnisindioneSevereDatabaseDDInter
- ApixabanSevereDatabaseDDInter
Mechanism
An antibody-drug conjugate (ADC) that combines trastuzumab with a cytotoxic agent, delivering chemotherapy directly to HER2-expressing cells.
Indications
For HER2-positive patients with residual invasive disease at surgery after neoadjuvant therapy, to complete a year of therapy
Drug interactions
Acalabrutinib
Severe
Database
Drug interaction classified as: synergy
Source: DDInter
Anisindione
Severe
Database
Drug interaction classified as: synergy
Source: DDInter
Apixaban
Severe
Database
Drug interaction classified as: synergy
Source: DDInter
Ardeparin
Severe
Database
Drug interaction classified as: synergy
Source: DDInter
Argatroban
Severe
Database
Drug interaction classified as: synergy
Source: DDInter
Aspirin
Severe
Database
Drug interaction classified as: synergy
Source: DDInter
Avapritinib
Severe
Database
Drug interaction classified as: synergy
Source: DDInter
Betrixaban
Severe
Database
Drug interaction classified as: synergy
Source: DDInter
Bivalirudin
Severe
Database
Drug interaction classified as: synergy
Source: DDInter
Cabozantinib
Severe
Database
Drug interaction classified as: synergy
Source: DDInter
Cangrelor
Severe
Database
Drug interaction classified as: synergy
Source: DDInter
Related guidelines
Coeliac disease
OTHER · Gastroenterology · 2016
Inflammatory bowel disease
OTHER · Gastroenterology · 2015
Chronic kidney disease — assessment and management
KDIGO · Nephrology · 2024
Invasive candidiasis
IDSA · Infectious Diseases · 2016
Preoperative cardiac evaluation for non-cardiac surgery
AHA · Cardiology · 2025
Other Unclassified drugs
Ask House about trastuzumab emtansine
Continue into a citation-backed clinical answer with the drug context already attached.
Sources: Harrison 22e·Verified: 2026-05-10 · House clinical team